Scaling New Heights: Establishing a Robust Control Strategy for Oligonucleotide Drug Development
Time: 11:05 am
day: Pre-Conference Day
Details:
Increasing complexities tie in additional analytical, manufacturing and CMC considerations. Recognizing the common predicted failure sequences upon manufacturing and deep diving to discover how to mitigate these factors.
This workshop will gather experts to discuss:
- Ensuring process stability and controlled variables to ensure consistent product quality
- Debating scale-dependant factors such as impurities
